Stocks / NASDAQ / Ocera Therapeutics, Inc.

Ocera Therapeutics, Inc.

Our Opinion

Ocera Therapeutics, Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.

Supporting Evidence:

The company stated in the following press release that they conduct pre-clinical trials of their drugs on animals.

“The study investigated the effect of OCR-002 in an NAFLD rat model in which animals were fed a High Fat and High Cholesterol (HFHC) diet for up to 16 weeks.” Read the following article

Company Description

Ocera Therapeutics, Inc. is a clinical stage biopharmaceutical company. It engages in development and commercialization of OCR-002 (ornithine phenylacetate0 in intravenous and oral formulations. The company was founded by Wu Xiaoyun, John C. Kappes, and Eckard Weber on January 12, 1998 and is headquartered in Palo Alto, CA. [Source: MarketWatch]

Company Website: